Sarah Neidler,  —

Recent Posts

• Casgevy improved quality of life for severe SCD patients in trial
• Gene-editing therapy CS-101 used in SCD patient for first time
• How I found a safe workout routine with sickle cell
• Blood drive, walks planned as part of Sickle Cell Awareness Month
• As I navigate grief and loss, one thing is clear: We deserve better
• Oryzon cleared to start trial of sickle cell drug in Europe
• Inclacumab fails to reduce pain crises vs. a placebo in SCD trial
• Gene-edited cell therapy for severe SCD lands new FDA designation
• 4 months after a sickle cell pain crisis, I’m moving past recovery
• Even as a doctor, I’ve learned a lot from my experience as a caregiver